Skip to main content

JPMORGAN CHASE & CO

Position in EOLS — Evolus, Inc.

CIK 19617 NEW YORK, NY

Position in EOLS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$129,365
-$1,370,885 QoQ
Shares Held
31,476
-86.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 24% Shared 0% None 76%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $2,053,485,768 across 61 Drug Manufacturers - Specialty & Generic names. EOLS ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $129,365 31,476
2025-12-31 $1,500,250 225,602
2025-09-30 $2,740,348 446,311
2025-06-30 $6,377,794 692,486
2025-03-31 $8,756,527 727,891
2024-12-31 $1,525,163 138,149
2024-09-30 $2,752,799 169,926
2024-06-30 $2,321,398 213,954
2024-03-31 $3,467,184 247,656
2023-12-31 $405,119 38,473
2023-09-30 $1,196,425 130,900
2023-06-30 $248,408 34,169
2023-03-31 $252,090 29,798
2022-12-31 $829,597 110,466
2022-09-30 $188,232 23,383
2022-06-30 $249,666 21,523
2022-03-31 $250,340 22,312
2021-12-31 $111,405 17,113
2021-09-30 $93,070 12,214
2021-06-30 $158,200 12,506
2021-03-31 $260,214 20,032
2020-12-31 $212,129 63,134
2020-09-30 $31,877 8,153
2020-06-30 $39,086 7,375
2020-03-31 $24,696 5,951